Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
暂无分享,去创建一个
K. Chayama | M. Kurosaki | M. Sakamoto | A. Tamori | N. Sakamoto | Y. Takikawa | Yasuhito Tanaka | T. Tatsumi | T. Takehara | Y. Ueno | T. Kanda | E. Mita | H. Dvory‐Sobol | D. Brainard | H. Yatsuhashi | S. Nishiguchi | L. Stamm | F. Ikeda | Takuma Matsuda | S. De‐oertel | Gulan Zhang